TLR5
Basic information
Region (hg38): 1:223109404-223143292
Previous symbols: [ "SLEB1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TLR5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 38 | 53 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 38 | 13 | 9 |
Variants in TLR5
This is a list of pathogenic ClinVar variants found in the TLR5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-223110480-A-G | not specified | Uncertain significance (Dec 06, 2022) | ||
1-223110495-T-C | not specified | Benign/Likely benign (Mar 01, 2023) | ||
1-223110501-T-C | not specified | Uncertain significance (Mar 15, 2024) | ||
1-223110520-T-C | not specified | Uncertain significance (Apr 08, 2024) | ||
1-223110539-T-C | Benign/Likely benign (Mar 01, 2023) | |||
1-223110627-T-C | not specified | Uncertain significance (Sep 29, 2022) | ||
1-223110672-A-G | not specified | Uncertain significance (Mar 28, 2024) | ||
1-223110708-G-C | not specified | Uncertain significance (May 25, 2022) | ||
1-223110715-T-C | not specified | Uncertain significance (May 31, 2022) | ||
1-223110769-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
1-223110778-T-C | Benign (Dec 31, 2019) | |||
1-223110795-T-G | not specified | Likely benign (Mar 12, 2024) | ||
1-223110828-A-G | not specified | Uncertain significance (Jan 10, 2023) | ||
1-223110872-A-T | TLR5-related disorder | Likely benign (Jan 10, 2023) | ||
1-223110913-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
1-223110934-T-C | not specified | Uncertain significance (Aug 04, 2023) | ||
1-223111041-C-T | not specified | Uncertain significance (Dec 01, 2022) | ||
1-223111067-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
1-223111072-G-A | not specified | Uncertain significance (Jun 09, 2022) | ||
1-223111102-T-A | not specified | Benign/Likely benign (Mar 01, 2023) | ||
1-223111175-A-T | TLR5-related disorder | Likely benign (Sep 17, 2019) | ||
1-223111180-C-T | not specified | Uncertain significance (Jun 13, 2024) | ||
1-223111186-A-G | TLR5-related disorder | Benign (Oct 17, 2019) | ||
1-223111210-T-C | not specified | Uncertain significance (Oct 05, 2022) | ||
1-223111249-T-G | not specified | Uncertain significance (Sep 29, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TLR5 | protein_coding | protein_coding | ENST00000540964 | 1 | 33877 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.48e-13 | 0.0359 | 112631 | 459 | 12658 | 125748 | 0.0536 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.392 | 407 | 430 | 0.947 | 0.0000215 | 5688 |
Missense in Polyphen | 102 | 117.92 | 0.86498 | 1695 | ||
Synonymous | -0.326 | 178 | 173 | 1.03 | 0.00000884 | 1683 |
Loss of Function | 0.206 | 20 | 21.0 | 0.951 | 0.00000109 | 289 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0481 | 0.0480 |
Ashkenazi Jewish | 0.0286 | 0.0286 |
East Asian | 0.0282 | 0.0282 |
Finnish | 0.0465 | 0.0467 |
European (Non-Finnish) | 0.0625 | 0.0623 |
Middle Eastern | 0.0282 | 0.0282 |
South Asian | 0.104 | 0.103 |
Other | 0.0504 | 0.0506 |
dbNSFP
Source:
- Function
- FUNCTION: Participates in the innate immune response to microbial agents. Mediates detection of bacterial flagellins. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. {ECO:0000269|PubMed:11323673}.;
- Disease
- DISEASE: Systemic lupus erythematosus 1 (SLEB1) [MIM:601744]: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Salmonella infection - Homo sapiens (human);Legionellosis - Homo sapiens (human);Inflammatory bowel disease (IBD) - Homo sapiens (human);Toll-like receptor signaling pathway - Homo sapiens (human);Pathogenic Escherichia coli infection - Homo sapiens (human);Regulation of toll-like receptor signaling pathway;Pathogenic Escherichia coli infection;Toll-like Receptor Signaling;Simplified Depiction of MYD88 Distinct Input-Output Pathway;Toll-like Receptor Signaling Pathway;MyD88 cascade initiated on plasma membrane;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 5 (TLR5) Cascade;Toll-Like Receptors Cascades;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.266
Intolerance Scores
- loftool
- 0.654
- rvis_EVS
- 1.65
- rvis_percentile_EVS
- 96.21
Haploinsufficiency Scores
- pHI
- 0.0769
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.400
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.974
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tlr5
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype;
Gene ontology
- Biological process
- MyD88-dependent toll-like receptor signaling pathway;inflammatory response;positive regulation of interleukin-8 production;positive regulation of toll-like receptor signaling pathway;toll-like receptor 5 signaling pathway;defense response to bacterium;innate immune response;regulation of cytokine secretion;cellular response to mechanical stimulus
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function
- transmembrane signaling receptor activity;interleukin-1 receptor binding